Dieses Ergebnis aus Springer Nature Journals kann Gästen nicht angezeigt werden. Login für vollen Zugriff.

TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)

Title:	TLD-1, a Novel Liposomal Doxorubicin, in Patients with Solid Tumors: Comparative Pharmacokinetics and Final Results of a Multicenter Phase 1 Study (SAKK 65/16)
Authors:	Klose, Marian^{Aff1, Aff2}; Colombo, Ilaria^Aff3; Gobat, Katrin^Aff4; Koster, Kira-Lee^Aff5; Haefliger, Simon^Aff6; Rabaglio, Manuela^Aff6; Bastian, Sara^Aff7; Schwitter, Michael^Aff7; Zürrer-Härdi, Ursina^Aff8; Eckhardt, Katrin^Aff4; Hayoz, Stefanie^Aff4; Halbherr, Stefan^Aff9; Sessa, Cristiana^Aff3; Michelet, Robin^Aff1; Mc Laughlin, Anna M.^{Aff1, Aff10}; Hess, Dagmar^Aff5; Stathis, Anastasios^Aff3; Kloft, Charlotte^{Aff1, Aff2}; Joerger, Markus^{Aff5, Aff11, IDs4026202501588z_cor1}
Source:	Clinical Pharmacokinetics. 65(2):217-228
Database:	Springer Nature Journals